News

The Ministry of Health (MH) sent Brazilian National Health Surveillance Agency (Anvisa) a request for exemption from the sanitary registration, on an … Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health

On August 8th, 2022, during the 12th Extraordinary Public Meeting of DICOL, ANVISA’s Collegiate Board of Directors announced the completion of the toxicological … Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

Our partner and head of Life Sciences, Priscila Kashiwabara discusses plant variety protection in Brazil and its recent developments regarding legal framework for Plant … Protecting Plant Varieties in Brazil for FloraCulture Magazine

In December 2019, ANVISA started the process of toxicological revaluation of the Active Ingredient (AI) Carbendazim, as signs of toxicity were identified … Carbendazim toxicological revaluation about to be completed by ANVISA

Good news for patent owners in Brazil: the National Congress has upheld the President’s veto n° 48/2021, which prevented those who had their … Compulsory license: patent owners in Brazil are under no obligation to provide know-how and raw materials

Provisional Measure 1,124/22 published this past June 14, 2022, transformed the Brazilian Data Protection Authority into a special nature entity. The Measure is … Provisional Measure Transforms the Brazilian Data Protection Authority into an Independent Entity

At the end of the 12th Ministerial Conference (MC12) of the World Trade Organization (WTO) which took place last Friday (June 17th), an … Latest WTO decision establishes a waiver to patent owner’s rights related to COVID-19 vaccines in developing countries

On 7 June 2022, in the Official Gazette 2683, the Brazilian patent office published a communication regarding the new standard for submission … INPI publishes communication on new sequence listing standard for patent applications in Brazil

On June 1, 2022, the public consultation of the BPTO’s Technical Note CPAPD nº 01/2022 was published in the Federal Official Gazette n° … Brazilian PTOs opens public consultation on inventions related to transgenic plants

The IX Conference on Civil Law took place in May 19 and 20, 2022, which also celebrated the 20th anniversary of the Brazilian … IX Conference on Civil Law and the impacts on Digital Law

Web 3.0 is the new global trend that will impact modern society and the way people relate to the internet. It refers … Have you heard about the Web 3.0?

On March 17, 2022, the BPTO released the INPI/CPAPD technical note No. 01/2022, which provides guidance on the patentability of inventions involving … Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that … Life sciences patent eligibility in Latin America: a guide

Yesterday (Feb. 10, 2022), the Brazilian Senate approved the Constitutional Amendment no. 115/2022, originated in the Proposal for Constitutional Amendment no. 17/2019, … Data Protection becomes a fundamental right in Brazil

On February 8th, 2022, the Brazilian Patent Office reported the decision to apostille letters-patent when the patent protects subject-matter going beyond the … News on apostille of letters-patent retroactively affected by the Direct Plea of Unconstitutionality 5,529